Latest Breaking News On - Kindred biosciences inc - Page 5 : comparemela.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SYKE, TGRF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SYKE, TGRF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
SHAREHOLDER ALERT: WeissLaw LLP Reminds CVA, SWN, RIVE, and KIN Shareholders About Its Ongoing Investigations
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
SHAREHOLDER ALERT: WeissLaw LLP Reminds CVA, SWN, RIVE, and KIN Shareholders About Its Ongoing Investigations
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
.
Kindred Biosciences, Inc. (NASDAQ: KIN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Elanco Animal Health Incorporated for $9.25 per share.
If you are a Kindred Biosciences shareholder,
.
Monmouth Real Estate Investment Corporation (NYSE: MNR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Equity Commonwealth. Under the terms of the merger agreement, Monmouth shareholders will receive 0.67 shares of Equity Commonwealth stock for each Monmouth share they own.
If you are a Monmouth shareholder,
.
Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.